Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 28, 2021

SELL
$77.92 - $102.4 $205,708 - $270,336
-2,640 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$84.4 - $177.39 $122,380 - $257,215
1,450 Added 121.85%
2,640 $365,000
Q3 2020

Nov 03, 2020

BUY
$72.98 - $90.0 $86,846 - $107,100
1,190 New
1,190 $98,000

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.13B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Illinois Municipal Retirement Fund Portfolio

Follow Illinois Municipal Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Illinois Municipal Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Illinois Municipal Retirement Fund with notifications on news.